Skip to main content

Dhruv Anand and Udita M. Patro look at the trend of Indian courts granting larger damages in IP cases, particularly those concerned with trademark infringement.

With the Indian legislature and judiciary realizing the increasingly important need to safeguard and protect the intellectual property assets of a company, intellectual property litigation in India has recently received a heartening – and much-required and awaited – thrust with the recent enactment of the Commercial Courts Act, which has brought about a time revolution in such cases, and the recent trend of Indian judges granting larger damage amounts in intellectual property cases.

A recent judgment of the Delhi High Court wherein the court recognised and upheld the well-known YAHOO trademark of Yahoo! Inc., while granting damages to the tune of Rs. 3.2 million (US$48,000) and costs of Rs. 640,000 (US$9,600) is an apt illustration of this recent trend.

In another suit for counterfeiting and trademark infringement, Cartier International AG v. Gaurav Bhatia, the Delhi High Court awarded Rs. 10 million (US$150,200) in damages. The judgments point to the changing approach of Indian courts and their willingness to grant high damages in intellectual property cases, proportionate, at least partly, to the illicit commercial exploitation by the infringer.

This article was published in Asia IP October 2016.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions
Thought Leadership
•
Oct 15, 2026

First published on Enterprise IT World. Authored by Subroto Kumar Panda Imagine you gave a supersmart robot a credit card and told it to “buy the best

Taming the AI Beast: How Big Companies Build Safe AI Agents